PharmaTher Holdings Faces Regulatory Hurdles and Financial Struggles Amid FDA Ketamine Review Delay
PharmaTher Holdings Ltd. is facing significant challenges, including a delayed FDA review for its ketamine application and financial instability, but its launch of KetaVault, a portal to accelerate ketamine research, offers a glimmer of hope.
3 minutes to read